Einkommen von Novo Nordisk ist kr52.825B
Das für Stammaktionäre verfügbare Nettoeinkommen entspricht dem Nettoeinkommen abzüglich der gezahlten Vorzugsdividenden.
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.